Here’s why the Next Science (ASX:NXS) share price finished higher today
The medical research company has finished the day strongly after one of its products was given TGA approval.
Full Article
Here’s why the Next Science (ASX:NXS) share price finished higher today
Motley Fool
0 shares
1 views
You might like
Related news coverage
Cervantes Corporation raises more than $3.36 million to advance exploration work
Proactive Investors
Cervantes Corporation Limited (ASX:CVS) has raised more than $3.36 million after completing the capital raisings announced on April..
-
NA Proactive news snapshot: Kintara Therapeutics, PlantX Life, Binovi Technologies, Atlas Engineered Products, ImagineAR UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: Mydecine Innovations, Aion Therapeutic, EVmo, Alpine 4, Dalrada UPDATE...
Proactive Investors
-
NA Proactive news snapshot: Mydecine Innovations, Aion Therapeutic, EVmo, Alpine 4, Arizona Silver UPDATE...
Proactive Investors
-
NA Proactive news snapshot: PharmaDrug, Kintara Therapeutics, QC Copper and Gold, New Pacific Metals UPDATE …
Proactive Investors
Advertisement
More coverage
NA Proactive news snapshot: Phunware, Bam Bam Resources, ElectraMeccanica Vehicles, Century Global Commodities …
Phunware Inc (NASDAQ:PHUN) (FRA:2RJ), a fully integrated enterprise cloud platform for mobile, reported that it ended its first..
Proactive Investors
Next Science (ASX:NXS) share price falls despite ‘exciting future ahead’
The Next Science Ltd (ASX: NXS) share price slumped today following the company's 2021 AGM presentation. Let's take a closer look.
Motley Fool